Videos de Experimentos Relacionados
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial.
ESMO open·2025
Same author
Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author
Counterpoint: Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?
Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.
Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author
Breast radiotherapy: less is more?
Clinical oncology (Royal College of Radiologists (Great Britain))·2012
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026